BPC-157 / TB-500 (Thymosin β4 fragment): preparation and storage
Intended for research use only. Not a medicinal product.
Contents (7 sections)
BPC-157 + TB-500: individual component concentrations
The BPC-157 + TB-500 blend names two components but does not define their mass ratio. BPC-157 is the pentadecapeptide GEPPPGKPADDAGLV. TB-500 requires separate confirmation of sequence and terminal modifications: the commercial name does not always distinguish a short fragment from full-length thymosin β4. An experiment using the full-length protein does not establish the activity of every reagent bearing this label.
Without each component’s mass in the CoA, only total mg/mL can be calculated. If documentation specifies mB mg BPC-157, mT mg TB-500 and final volume V mL, the respective concentrations are mB/V and mT/V mg/mL. Calculate molarity separately using each verified molecular mass; “blend molarity” is not unambiguous. Do not assume a 1:1 ratio from the name. Testing an interaction requires each component alone, the mixture and a vehicle control, rather than the mixture versus untreated cells alone.
Stock analysis must resolve both components rather than measure only total absorbance at one wavelength. Different response factors mean uncalibrated peak areas cannot establish a mass ratio. High overall purity does not verify the claimed ratio. If one component dissolves incompletely, removing precipitate changes mixture composition. Record composition before filtration and measure each component’s recovery afterwards. Comparisons with full-length thymosin require a separate group using authenticated protein.
Which evidence concerns BPC-157 and which concerns thymosin?
In 2011, Chang and colleagues studied BPC-157 in rat Achilles tendon explants and fibroblasts. The peptide increased explant outgrowth, transwell migration and cell spreading. Direct proliferation in the MTT assay was not enhanced, whereas survival under H₂O₂ stress increased. This distinction matters: migration should not be described as generally accelerated cell division.
The study also assessed F-actin and phosphorylation of FAK and paxillin; total amounts of these signaling proteins did not change as their phosphorylated state did. Replication requires normalization of corresponding Western blot bands rather than comparison of total protein alone. None of these endpoints by itself proves that adding TB-500 enhances BPC-157 effects or preserves it in a blend.
In 1999, Malinda and colleagues examined thymosin β4 in a rat full-thickness wound model and keratinocyte migration in a Boyden chamber. The saline-control comparison concerned thymosin β4 rather than a prepared BPC-157 + TB-500 blend. This study provides context only after matching the second component’s structure. If your vial contains a short fragment, full-length thymosin activity does not establish its equivalence.
Preparing a paired experiment
Create separate records for both components: sequence, terminal groups, salt, quantitative content and identification method. For BPC-157, verify the stated pentadecapeptide structure. For TB-500, the cap label does not replace a sequence. If the COA specifies total mass only, record that limitation: neither equal fractions nor equal molar amounts follow from that document.
Take a small trial portion for dissolution in the vehicle specified for the mixture. Check it in the final fibroblast medium or other selected model. Stock compatibility with water does not guarantee absence of changes after adding salts and serum. Compare with individually prepared components in the same vehicle. Heating, pH adjustment or removal of precipitate without component analysis can change composition rather than simply appearance.
Calculating each component
A strictly hypothetical example that does not describe the product: if 2.00 mg BPC-157 and 3.00 mg of a verified TB-500 form are documented, a final 2.50 ml gives concentrations of 0.800 and 1.20 mg/ml. The sum is 2.00 mg/ml, but neither component has that concentration. This shows why total blend mass cannot be stated as each peptide’s mass.
Adding 25.0 µl of this hypothetical stock to a final 1.00 ml gives a dilution factor of 40. The sample contains 0.0200 mg/ml BPC-157 and 0.0300 mg/ml of the second component, totaling 0.0500 mg/ml. The BPC-157 control should contain the first concentration and the TB-500 control the second. Equal total mg in two control wells do not reproduce blend composition. For molar comparison, each verified form needs its own molecular weight.
Distinguishing migration from cell number
In a scratch assay, gap closure may depend on movement, proliferation and survival. To draw conclusions about migration, use an appropriate design and independent viability assessment. In transwell experiments, check starting cell number and serum concentration on both sides of the membrane. A blend that changes survival in one condition can change membrane cell counts without directly increasing movement speed.
Include vehicle, BPC-157, the verified second component and their mixture at matched component concentrations. Assessing interaction requires several levels of both peptides and a predefined comparison model. Superiority of the mixture over vehicle does not prove synergy. If full-length thymosin β4 is used as a reference for a fragment, keep it as a separately labelled group.
Stability of the paired stock
For a stored mixture, determine both intact components rather than total UV signal alone. The method must distinguish their peaks and principal conversion products. Even an unchanged signal sum can conceal loss of one component and formation of another peak. Check recovery after filtering, transfer and thawing separately for both peptides; a shared tube does not guarantee equal recovery.
Store dry blend according to its own label, and use refrigerated or frozen solution storage only under a verified mixture procedure. A universal period for one isolated peptide does not establish a period for two. Can more volume simply be added after precipitation? Only after establishing pellet composition and reversibility. Does clarity prove the correct ratio? Quantitative component data are needed. General technique appears in the storage guide.
End of article
BPC-157 + TB-500 Blend
for laboratory research
Packs and current prices on the product page.